Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
AssigneeMerck Sharp & Dohme Corp.
InventorsTesfaye Biftu, Ann E. Weber
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
Claims2
A method of treating diabetes in a patient comprising administering to a patient in need thereof a therapeutically effective amount of a compound which is:
- or a pharmaceutically acceptable salt in combination with a sodium-glucose transporter (SGLT) inhibitor.
Dependencies are inferred from the claim text.